Hospice of Arizona: Admission Targets, Delayed Discharges, and Higher Bills

The Hospice of Arizona lawsuit ended in a $12 million settlement over allegations that the company billed Medicare for patients who did not qualify for hospice or for the level of care claimed. The government alleged pressure to meet admissions and census targets, procedures that delayed discharges, and a failure to put adequate compliance controls in place in time. For an insider who watched clinical decisions bend toward a census goal, this case reaches beyond the bill to the instructions that kept patients on the rolls.

The Department of Justice announced the settlement on March 20, 2013. A former employee brought the qui tam case under the False Claims Act. The alleged hospice fraud combined decisions about who entered, who stayed, and how their care was billed. Taxpayers paid for the care that those decisions put on Medicare’s bill.

What Did the Hospice of Arizona Lawsuit Allege?

The government alleged false Medicare claims from September 1, 2002 through December 31, 2010. Some patients allegedly lacked a terminal prognosis of six months or less if their illness ran its normal course. Others had that prognosis but did not qualify for the level of care billed.

The eligibility allegations reached the way the business managed its staff. According to the Justice Department, Hospice of Arizona pressured employees to meet admissions and census targets and adopted procedures that delayed and discouraged discharge of ineligible patients. The government also alleged a failure to implement an adequate compliance program in time.

Those alleged practices worked on different parts of the same patient population. Admissions targets pressed staff to bring people in. Discharge restrictions helped keep them there.

That is why the discharge allegation matters as much as the admission allegation. A clinical employee may encounter the problem when a patient should leave hospice, after the original admission paperwork has already been signed. The question then becomes what happened to that assessment and why billing continued.

The stakes in this kind of health care fraud extend to the treatment a patient gives up. Medicare hospice does not pay for treatment to cure a patient’s terminal illness. As the Department of Health and Human Services inspector general explains, an inappropriate enrollment can mean forgoing needed treatment.

Why Higher-Level Hospice Billing Matters

The higher-level billing allegation concerned patients who could qualify for hospice but did not qualify for the care level on the claim. The patient’s prognosis answered one question. The care billed to Medicare answered another.

Medicare pays for routine home care by the enrolled day. Continuous home care serves a crisis at home. General inpatient care addresses symptoms that cannot be managed elsewhere. As the Medicare Payment Advisory Commission explains in its March 2026 hospice report, these are different care categories with different payment arrangements. For someone reviewing billing, the useful comparison is between the care the patient needed, the care provided, and the level charged for those dates.

Daily payment also explains why keeping patients enrolled can be financially attractive. Hospice costs tend to be highest around admission and death, with fewer services in the middle of a stay. MedPAC describes longer stays as more profitable because more of the episode falls in that lower-cost middle. A delayed discharge can preserve paid days while a higher care level changes the amount claimed for care.

The 2026 Kansas State University working paper Quality, Reputation, and Reimbursement Design in the Hospice Industry models competition among California hospices. It finds that a reputation for care helps attract patients and that providing more visits carries additional cost. Its model predicts that combining payment by day with payment by visit could maintain quality at lower Medicare spending, measuring quality through visits per patient day.

Providing more care costs money. Keeping an enrolled patient brings in daily payment. In the Arizona case, the government’s allegations focused on how admissions, discharge practices and billing decisions turned those incentives into claims Medicare should not have paid.

The Settlement Reached the Management Company and Parent

The operating hospice was in Arizona. The settlement named Hospice of Arizona, L.C., American Hospice Management, LLC, and their parent corporation, American Hospice Management Holdings, LLC.

The management company and parent were settling defendants alongside the operating hospice. The Justice Department described the alleged conduct as submitting false claims or causing their submission.

The Whistleblower Award and the Compliance Agreement

The Justice Department said the former employee who brought the case would receive $1.8 million as the whistleblower’s share of the recovery.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. Here, an employee’s case reached the hospice, its management company and its parent. The employee’s position inside the business matters to the story because the government’s allegations concerned how staff were directed, as well as what Medicare was billed.

American Hospice Management Holdings agreed to a five-year corporate integrity agreement with the Department of Health and Human Services Office of Inspector General. The Justice Department described procedures and reviews designed to avoid and promptly detect conduct like that underlying the settlement.

What Evidence Is Needed to Prove Fraud?

For allegations like these, the evidence needs to connect the patient’s condition and care to the Medicare claim and the decisions behind it. We examine what the clinical record supported, what the claim said, and how management responded when those accounts diverged.

The useful account is specific to the work you saw. An intake employee may know how a target affected admission decisions. A clinician may know what happened to a discharge recommendation. A billing employee may know which care level went onto the claim. We work with you to connect that knowledge across the patient record, management’s instructions and Medicare billing.

Census Pressure in Other Hospice Cases

Other hospice complaints show how census pressure can reach a clinical decision. In a whistleblower case against Evercare Hospice that the government joined, the government’s complaint described management blocking a patient’s request to leave hospice:

The stated reason was the census. That passage makes the management pressure concrete: a decision about leaving hospice allegedly became a decision about how many patients the business would retain.

In a separate whistleblower complaint against Agape Senior Community, the allegation concerned keeping patients at the general inpatient level:

These complaints expose different versions of a similar problem: a business objective allegedly steering whether care continued and at what level. Hospice of Arizona’s settlement brought eligibility, discharge practices and care-level billing together. For an insider, the connection between those departments may explain more than any single claim does.

You Saw What the Census Target Changed

If you saw admissions, discharge decisions or care-level billing bend to a census target, speak to one of our whistleblower experts about what happened inside the hospice. We develop your healthcare whistleblower case with you, bring in hospice fraud whistleblower lawyers who understand clinical records and Medicare billing, and stay beside you through the pursuit of a recovery.